Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00632372 · ClinicalTrials.gov registry record
Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 8
- Enrollment target
NCT00632372: Completed study, sponsored by Abbott Medical Devices.
NCT00632372 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00632372 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to collect and analyze electrical measurements, timing, and signals from a CRT-D device in heart failure patients who either already have an implanted left atrial pressure sensor or will undergo a simultaneous implantation of a left atrial pressure sensor and a CRT-D device. These devices may be placed at the same time or separately (staged procedure) at the discretion of the investigator. A comparison will be made between the information gathered from the CRT-D system and the information gathered by the left atrial pressure sensor.
Interventions
- DEVICE Cardiac Resynchronization Therapy
- DEVICE HeartPOD™ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-01 |
| Est. Completion | 2015-12 |
What the finished NCT00632372 record still lists
NCT00632372 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Cardiac Resynchronization Therapy is the first listed.
NCT00632372 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00632372 about?
NCT00632372 is a clinical study titled "Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study". The purpose of this study is to collect and analyze electrical measurements, timing, and signals from a CRT-D device in heart failure patients who either already have an implanted left atrial pressure sensor or will undergo a simultaneous implantation of a left atrial pressure sensor and a CRT-D dev...
What is the current status of trial NCT00632372?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2008-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00632372?
The interventions under investigation include: Cardiac Resynchronization Therapy (DEVICE), HeartPOD™ System (DEVICE).
Who is sponsoring clinical trial NCT00632372?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia